Condition: Tricuspid Regurgitation Functional · Sponsor: Cardiac Implants LLC
An early feasibility study to evaluate the safety and performance of 1) the transcatheter delivery and implantation of the Cardiac Implants (CI) annuloplasty ring and 2) the adjustment of the ring approximately 90 days following implantation in patients suffering from ≥ moderate functional tricuspid regurgitation (FTR).
This description comes directly from the study's public registry record.
Nodar Kipshidze, MPH · 1-917-370-6247 · Nodar@cardiac-implants.com
Always discuss trial participation with your own doctor first.
| Hackensack University Medical Center | Hackensack, New Jersey, United States | Not Yet Recruiting |
| Weill Cornell Medicine-New York Presbyterian Hospital | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04890821